The U.S. Food and Drug Administration (FDA) acted today to approve Lipfendra (enlicitide), the first drug taken by mouth that ...
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
The pill, branded as Lipfendra, is intended to treat patients with hypercholesterolemia, including those with hereditary ...
The US FDA approved Merck’s cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated by ...
The Food and Drug Administration approved a daily pill Thursday called Lipfendra, which is designed to send cholesterol ...
Pittsburgh doctors on Thursday hailed government approval of a highly effective anti-cholesterol pill that had previously ...
The drug is the first oral form of a class of powerful cholesterol-fighting drugs called PCSK9 inhibitors.
The FDA has approved Lipfendra, a new daily oral medication for high cholesterol. This drug belongs to a newer class of ...
Everyday Health on MSN
The FDA just approved a new medication to treat high cholesterol
Lipfendra (enlicitide) is the first PCSK9 inhibitor in a pill, and can help get LDL ‘bad’ cholesterol in check when statins ...
US drug regulators signed off on a new pill designed to lower cholesterol levels far beyond what traditional statins can achieve.
The U.S. Food and Drug Administration has approved Merck's Lipfendra (enlicitide), making it the first oral PCSK9 inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results